11-60061308-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006138.5(MS4A3):āc.148G>Cā(p.Val50Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000224 in 1,606,618 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006138.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MS4A3 | NM_006138.5 | c.148G>C | p.Val50Leu | missense_variant | 2/7 | ENST00000278865.8 | |
MS4A3 | NM_001031809.2 | c.148G>C | p.Val50Leu | missense_variant | 2/6 | ||
MS4A3 | NM_001031666.2 | c.-75-2954G>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MS4A3 | ENST00000278865.8 | c.148G>C | p.Val50Leu | missense_variant | 2/7 | 1 | NM_006138.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000496 AC: 12AN: 242132Hom.: 0 AF XY: 0.0000535 AC XY: 7AN XY: 130870
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1454304Hom.: 0 Cov.: 30 AF XY: 0.00000968 AC XY: 7AN XY: 723352
GnomAD4 genome AF: 0.000138 AC: 21AN: 152314Hom.: 1 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 06, 2022 | The c.148G>C (p.V50L) alteration is located in exon 2 (coding exon 1) of the MS4A3 gene. This alteration results from a G to C substitution at nucleotide position 148, causing the valine (V) at amino acid position 50 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at